Current Headlines

  1. Cancer Drug And Antidepressants Provide Clues For Treating Fatal Brain-Eating Amoeba Infections
    9/13/2018

    The amoeba Naegleria fowleri is commonly found in warm swimming pools, lakes and rivers

  2. Health Canada Reclassifies Tetra Bio-Pharma’s Inhalation Device Making It Eligible For Reimbursement
    9/13/2018

    Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, announced today that Health Canada has re-classified the inhalation pipe device used in the delivery of its PPP001 cannabis drug to a Class 2 Medical Device

  3. Newly Formed PMI BioPharma Solutions Announces Launch Of Research Lab And Manufacturing Facilities Tailored To The Pharmaceutical And Biopharmaceutical Industry
    9/13/2018

    PMI BioPharma Solutions (https://pmibio.com/) officially formed in January of 2018, has established complete research and manufacturing operations at multiple sites located in both Nashville and Celina Tennessee

  4. Scientists Discover Influenza Protein Behavior That Could Aid Drug Development
    9/12/2018

    Influenza A viruses are highly adaptable, managing to infect and replicate rapidly and to spread efficiently from person to person

  5. SAMDI Tech Partners With Charles River To Expand Small Molecule Screening Collection
    9/11/2018

    SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has partnered with Charles River Laboratories, which provides products and services that accelerate research and drug development efforts, to expand its small molecule screening collection and maximize its clients’ opportunities to discover hit compounds for their drug discovery projects

  6. Variation In Cancer-Causing KRAS Mutations Greater Than Thought
    9/11/2018

    The effects of KRAS mutations underlying many different types of cancer are more diverse than previously thought, according to a new study led by the University of Eastern Finland. Different mutations in the same amino acid of the KRAS protein have so varied effects on protein function that they may require different approaches when it comes to treatment and drug development.

  7. World First At Cardiff And Vale UHB In New Treatment For Type 1 Diabetes
    9/11/2018

    A ground-breaking clinical trial has been launched in Cardiff to help prevent and manage the chronic autoimmune disease Type 1 diabetes

  8. Optibrium And Intellegens Collaborate To Apply Novel Deep Learning Methods To Drug Discovery
    9/11/2018

    Optibrium, a developer of software for drug discovery, recently announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software

  9. Early Stage Clinical Trial Of Antimalarial Drug Begins
    9/10/2018

    Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to treat malaria, as well as its effect on the human body

  10. New Drug Discovery Initiative Focused On Innovative Therapies
    9/10/2018

    The University of Sydney recently launched a new effort to drive a coordinated approach to drug discovery